[ Price : $8.95]
FDA announces additional changes in the way the Office of Regulatory Affairs operates.[ Price : $8.95]
FDA approves Bayers Ultravist (iopromide)-300 and Ultravist-370, iodine-based contrast agents for contrast-enhanced mammography.[ Price : $8.95]
FibroGen discontinues its ZEPHYRUS-2 Phase 3 trial of pamrevlumab in patients with idiopathic pulmonary fibrosis after topline dat...[ Price : $8.95]
Federal Register notice: FDA posts a draft guidance entitled Psychedelic Drugs: Considerations for Clinical Investigations.[ Price : $8.95]
ReShape Lifesciences files a PMA supplement for the companys next generation Lap-Band 2.0 for long-term treatment of obesity.[ Price : $8.95]
FDA approves a Pfizer NDA for Litfulo (ritlecitinib), a once-daily oral treatment for individuals 12 years of age and older with s...[ Price : $8.95]
FDA extends its review of UCB's psoriasis drug bimekizumab for reasons the company did not disclose.[ Price : $8.95]
FDA clears a CS Medical 510(k) for its Ethos Automated Ultrasound Probe Cleaner Disinfector.